Bottom line
RTISX vs IDEV: the short answer
RTISX (Multifactor International Equity Fund) and IDEV (iShares Core MSCI International Developed Markets ETF) are both mutual funds.
But IDEV is far broader, holding 2,337 positions to 609 for RTISX, so beyond the top names it adds exposure RTISX doesn't have.
IDEV is cheaper at 0.04% vs 0.94% — a difference of $90 a year per $10,000 invested.
Over five years, RTISX returned +9.4% a year vs +5.0% for IDEV (reporting dates differ).
Updated Nov 19, 2026
RTISX vs IDEV side by side
| RTISX | IDEV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Russell | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.94% | 0.04% |
| Annual cost per $10k | $94 | $4 |
| 10-yr cost on $10k (prospectus) | $1,187 | $51 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.9% | +4.5% |
| 5-yr return (annualized) | +9.4% | +5.0% |
| 10-yr return (annualized) | +7.4% | — |
| Best quarter | +16.6% | +16.9% |
| Worst quarter | −24.7% | −24.0% |
| Net assets (fund) | $187.7M | $31.6B |
| Number of holdings | 609 | 2,337 |
| Portfolio turnover | 59% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RTISX | IDEV | Difference |
|---|---|---|---|
| 2024 | +4.5% | +4.5% | +0.0% |
| 2023 | +16.3% | +17.3% | −1.0% |
| 2022 | −13.3% | −14.9% | +1.6% |
| 2021 | +13.8% | +12.7% | +1.1% |
| 2020 | +2.5% | +8.4% | −5.9% |
| 2019 | +18.6% | +23.4% | −4.8% |
| 2018 | −15.0% | −14.3% | −0.7% |
Source: Fund prospectus bar charts
Holdings overlap
16 of RTISX's top 25 holdings also appear in IDEV's top 25.
| Holding | RTISX | IDEV |
|---|---|---|
| ASML Holding NV | 2.33% | 2.19% |
| HSBC Holdings PLC | 1.43% | 1.24% |
| Shell PLC | 1.25% | 0.88% |
| Novartis AG | 1.05% | 0.98% |
| Roche Holding AG | 1.05% | 1.05% |
| Toronto-Dominion Bank/The | 1.01% | 0.68% |
| AstraZeneca PLC | 0.99% | 0.88% |
| Royal Bank of Canada | 0.95% | 1.00% |
| TotalEnergies SE | 0.92% | 0.59% |
| Nestle SA | 0.70% | 0.88% |
| Banco Santander SA | 0.68% | 0.70% |
| Allianz SE | 0.67% | 0.65% |
| ABB Ltd | 0.65% | 0.53% |
| Mitsubishi UFJ Financial Group Inc | 0.62% | 0.82% |
| UBS Group AG | 0.59% | 0.57% |
Source: SEC Form N-PORT
RTISX top 10
- Russell Investments Trust Company Commingled Employee Benefit Funds Trust-U.S. Cash Management Fund — 2.42%
- ASML Holding NV — 2.33%
- HSBC Holdings PLC — 1.43%
- Shell PLC — 1.25%
- Novartis AG — 1.05%
- Roche Holding AG — 1.05%
- Toronto-Dominion Bank/The — 1.01%
- AstraZeneca PLC — 0.99%
- Royal Bank of Canada — 0.95%
- TotalEnergies SE — 0.92%
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
FAQ
What is the difference between RTISX and IDEV?
Which is cheaper, RTISX or IDEV?
Should I own both RTISX and IDEV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.